
Earendil Labs provides an AI-powered platform for accelerated discovery of antibody and protein therapeutics. The system combines deep learning, structural biology, and high-throughput biology to design antibody sequences, predict binding and developability, and validate results. The platform searches vast antibody sequence spaces, synthesizes libraries of millions of candidates, and iterates based on experimental feedback. It operates as a B2B SaaS/licensing platform for biotech product discovery. With growing data and scalable workflows, it aims to shorten drug development cycles and improve success rates.

Earendil Labs provides an AI-powered platform for accelerated discovery of antibody and protein therapeutics. The system combines deep learning, structural biology, and high-throughput biology to design antibody sequences, predict binding and developability, and validate results. The platform searches vast antibody sequence spaces, synthesizes libraries of millions of candidates, and iterates based on experimental feedback. It operates as a B2B SaaS/licensing platform for biotech product discovery. With growing data and scalable workflows, it aims to shorten drug development cycles and improve success rates.